GeneCentric Therapeutics
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 12838, Durham, North Carolina, 27...Phone Number
(919) 973-6544Website
www.genecentric.comRevenue
<$5 MillionIndustry
About GeneCentric Therapeutics
GeneCentric Therapeutics, Inc., a leader in gene expression biomarkers and next-generation companion diagnostic development, is based in Durham, North Carolina. The company has developed a deep pipeline of gene signatures and related diagnostic tests by parsing the complexity of tumor biology using their RNA-based Tumor and Immune Micro-Environment (rT(I)ME) Explorer platform and proprietary AI-based technology to identify responder populations to oncology therapeutics. Along with its ExpressCT technology, these signatures can be applied to liquid biopsy through its GenomicsNext platform. GeneCentric commercializes its technology through strategic collaborations with biopharmaceutical and diagnostics companies in applications throughout preclinical testing, clinical drug development, and commercialization lifecycle phases.Explore more
SIC Code 87,873NAICS Code 54,541Show moreGeneCentric Therapeutics Org Chart
Compare Similar Companies to GeneCentric Therapeutics
Compare insights from companies similar to GeneCentric Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
GeneCentric Therapeutics Tech Stack
A closer look at the technologies used by GeneCentric Therapeutics
Top Business Services Companies
Frequently Asked Questions Regarding GeneCentric Therapeutics
Sign Up For FreeTo access detailed company insights
GeneCentric Therapeutics, Inc., a leader in gene expression biomarkers and next-generation companion diagnostic development, is based in Durham, North Carolina. The company has developed a deep pipeline of gene signatures and related diagnostic tests by parsing the complexity of tumor biology using their RNA-based Tumor and Immune Micro-Environment... Read More
